Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Ulta’s Q2 Beats, Guides In-line – Analyst Blog

Zacks Market Commentaries (September 8th, 2009) Writes:
Ulta Salon Cosmetics & Fragrances Inc. (ULTA) recently reported better-than-expected fiscal second-quarter results driven by the launch of new stores. The company’s reported net income expanded nearly 56% year over year to $5.8 million, or 10 cents per share, which comfortably surpassed the Zacks Consensus Estimate of 5 cents. Ulta is a beauty retailer that provides one-stop shopping for prestige, mass and salon products and salon services in the U.S. The company offers a full-service salon in all of its 333 retail stores across 38 states, and also distributes products through the company's website. The Romeoville, Illinois-based retailer’s sales grew 9.8% year over year to $273.5 million, primarily driven by the addition of 50 new stores since the year-ago quarter. However, same-store sales fell 1.7% year over year, mainly due to a 3.9% decline in average ticket size, partially offset by a 2.2% rise in ...

Martek Biosciences Corp. – Aggressive Growth – Zacks Rank Buy

Zacks Market Commentaries (October 19th, 2008) Writes:
Martek Bioscience (MATK) announced in September that made it a multiple license and supply deal with an international food companies, Hero, Grupo Ricap, and Hochdorf Nutricare. Martek will supply all of companies' ARA and DHA for infant formula and children's food and milk, specially designed for a child's early life.

The deal allows Martek to continue its international expansion into Mexico, Europe, and China. Martek's proprietary DHA and ARA blend is used in approximately 95% of infant formulas sold in the U.S.

On Sep 4 Martek announced third-quarter earnings that included earnings per share of 28 cents. This market the fourth surprise in the past 4 quarters, as analysts were only expecting 24 cents. Revenues rose 14% year-over-year to $88.4 million.

Martek also raised full-year guidance during the announcement. The company expects earnings per share to be between $1.06 and $1.09,

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.